Share chart Freeline Therapeutics Holdings plc
Extended chart
Simple chart
About Freeline Therapeutics Holdings plc
Freeline Therapeutics Holdings plc, биотехнологическая компания клинической стадии, разрабатывает векторно-опосредованную трансформационную аденоассоциированный вирус (AAV) генную терапию для пациентов, страдающих наследственными системными инвалидизирующими заболеваниями. Ее передовой продукт-кандидат — вербринакоген сетпарвовек (FLT180a), кандидат в генно-терапевтические препараты, который находится на стадии 1/2 клинических испытаний у взрослых мужчин для лечения гемофилии B. Продукты компании также включают FLT190, который находится на стадии 1/2 клинических испытаний. more details| IPO date | 2020-08-07 |
|---|---|
| ISIN | US35655L1070 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.freeline.life |
| Цена ао | 6.48 |
| Change price per day: | 0% (6.48) |
|---|---|
| Change price per week: | 0% (6.48) |
| Change price per month: | 0% (6.48) |
| Change price per 3 month: | 0% (6.48) |
| Change price per half year: | 0% (6.48) |
| Change price per year: | +1.09% (6.41) |
| Change price per 3 year: | +431.15% (1.22) |
| Change price per 5 year: | 0% (6.48) |
| Change price per 10 year: | 0% (6.48) |
| Change price per year to date: | 0% (6.48) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Millennium Management LLC | 370543 | 15.23 |
| TFG Asset Management GP Ltd | 266666 | 10.96 |
| CHI Advisors LLC | 86654 | 3.56 |
| Morgan Stanley | 42434 | 1.74 |
| UBS Group AG | 34204 | 1.41 |
| Renaissance Technologies, LLC | 26360 | 1.08 |
| Harbor Capital Advisors, Inc. | 20352 | 0.84 |
| Northern Trust Corporation | 15659 | 0.64 |
| Rhumbline Advisers | 115 | 0 |
| Gradient Investments, LLC | 100 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Michael J. Parini J.D. | CEO & Executive Director | 2.16M | 1975 (50 years) |
| Mr. James Bircher | Chief Technical Operations Officer | N/A | 1968 (57 years) |
| Dr. Pamela Foulds M.D. | Chief Medical Officer | N/A | 1970 (55 years) |
| Mr. Paul M. Schneider | CFO & Director | N/A | 1971 (54 years) |
| Dr. Henning R. Stennicke Ph.D. | Chief Scientific Officer | N/A | 1968 (57 years) |
| Ms. Nicole Jones SPHR | Chief People Officer | N/A | 1971 (54 years) |
| Ms. Amy J. Spandau | Interim Head of Finance | N/A | 1975 (50 years) |
| Ms. Naomi Aoki | Senior Vice President of Corporate Communications & Investor Relations | N/A |
Address: United Kingdom, Stevenage SG FX, Stevenage Bioscience Catalyst - open in Google maps, open in Yandex maps
Website: https://www.freeline.life
Website: https://www.freeline.life
